Drug Co. Ex-CEO Liable For $1M FBAR Penalty
A pharmaceutical company's former CEO faces a $1 million penalty for failing to disclose a foreign bank account after a federal court decided Friday he recklessly disregarded his duty to file....To view the full article, register now.
Already a subscriber? Click here to view full article